IP Library Granted Patent US 12,420,092
Granted Patent B2
US 12,420,092 · App. 18/536,502 · Granted Sep 23, 2025

Systems for treating disordered breathing by comparing stimulated and unstimulated breathing

Inventors: Mark Gelfand (New York, NY); Kristofer J. James (Eagan, MN); Randy W. Westlund (St. Paul, MN); Antonios Panteleon (Nea Penteli, GR); Todd P. Goblish (Maple Grove, MN); Mark C. Lynn (St. Anthony, MN)
Assignee: ZOLL RESPICARDIA, INC.
A61N1/3601A61N1/3611A61N1/36171
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,420,092
App. No.
18/536,502
Granted
Sep 23, 2025
Kind
B2
Abstract

A means for treating breathing disorders by stimulating respiratory muscles or nerves to entrain respiratory systems while leaving respiratory drive intact. Embodiments of the invention employ frequency analysis to determine if appropriate stimulation energy is being applied.

Claims (80)

1. A system for providing disordered breathing therapy, the system comprising:

at least one cuff electrode configured to stimulate a phrenic nerve of a patient; and

an implantable pulse generator (IPG) configured to:

couple to the at least one cuff electrode,

provide an electrical stimulation signal to the at least one cuff electrode to stimulate the phrenic nerve at a stimulation frequency, wherein the stimulation frequency is lower than an intrinsic breathing rate of the patient,

determine a measure of therapy effectiveness based on a comparison of signals representative of patient respiration corresponding to unstimulated breathing to signals representative of patient respiration corresponding to stimulated breathing, and

control power adjusting circuitry configured to adjust a power of the electrical stimulation signal based on the measure of therapy effectiveness, wherein the IPG is configured to control the power adjusting circuitry to adjust the power of the electrical stimulation signal until the power is at an intensity sufficient to entrain respiration while leaving intrinsic drive to breathe intact.

2. The system of claim 1 , comprising:

at least one sensor configured to generate signals representative of patient respiration comprising the signals representative of patient respiration corresponding to unstimulated breathing and the signals representative of patient respiration corresponding to stimulated breathing; and

at least one processor configured to:

receive the signals representative of patient respiration, and

determine the measure of therapy effectiveness based on the signals representative of patient respiration.

3. The system of claim 2 , wherein the at least one sensor comprises a transthoracic impedance sensor.

4. The system of claim 2 , wherein the at least one sensor is configured to sense physiologic activity indicative of contraction of a muscle in response to the electrical stimulation signal.

5. The system of claim 2 , wherein the IPG comprises at least one processor embedded in the IPG and configured to receive the signals representative of patient respiration.

6. The system of claim 5 , wherein the at least one processor is configured to:

receive the signals representative of patient respiration over a period of time, and

process the signals representative of patient respiration via a histogram-based method.

7. The system of claim 6 , wherein the histogram-based method comprises:

a construction of a frequency distribution of patient breath lengths over the period of time in a respiratory range of patient breath lengths,

an identification of a selected band of patient breath lengths that is centered on the stimulation frequency,

a calculation of a first sum of occupancies of sensed patient breath lengths in a range of the selected band of patient breath lengths,

a calculation of a second sum of occupancies of all sensed patient breath lengths in the respiratory range of patient breath lengths, and

a calculation of the measure of therapy effectiveness as a ratio of the first sum over the second sum.

8. The system of claim 5 , wherein the at least one processor is configured to:

receive the signals representative of patient respiration over a period of time, and

process the signals representative of patient respiration via a spectrum-based method.

9. The system of claim 8 , wherein the spectrum-based method comprises:

a generation of a spectral frequency distribution for the signals representative of patient respiration over the period of time,

an identification of a stimulation frequency band centered on the stimulation frequency corresponding to stimulated breathing,

an identification of a respiration frequency band over a range of natural respiratory frequencies corresponding to unstimulated breathing, and

a calculation of the measure of therapy effectiveness based on a comparison of the stimulation frequency band and the respiration frequency band.

10. The system of claim 9 , wherein the comparison comprises one or more of: a ratio of spectral power in the stimulation frequency band with spectral power in the respiration frequency band,

a ratio of spectral power density in the stimulation frequency band with spectral power density in the respiration frequency band, or

a ratio of spectral magnitude in the stimulation frequency band with spectral magnitude in the respiration frequency band.

11. The system of claim 1 , wherein the IPG is configured to provide the electrical stimulation signal to the at least one cuff electrode to stimulate the phrenic nerve at a variable stimulation frequency based on the measure of therapy effectiveness.

12. The system of claim 1 , wherein the IPG is configured to:

increase the power of the electrical stimulation signal if the measure of therapy effectiveness is below a threshold, and

decrease the power of the electrical stimulation signal if the measure of therapy effectiveness is above the threshold.

13. The system of claim 1 , wherein the power adjusting circuitry is configured to adjust the power of the electrical stimulation signal by changing one or more of a stimulation current or a stimulation voltage.

14. The system of claim 13 , wherein the power adjusting circuitry is configured to adjust the power of the electrical stimulation signal by increasing or decreasing a current of the electrical stimulation signal by steps within a current range below 10 mA.

15. The system of claim 1 ,

wherein the electrical stimulation signal comprises a series of pulse trains delivered at the stimulation frequency, with each pulse train being composed of a series of individual pulses, and

wherein the power adjusting circuitry is configured to adjust the power of the electrical stimulation signal by changing one or more of: a duration of the individual pulses, an amplitude of the individual pulses, or a frequency of the individual pulses.

16. The system of claim 15 , wherein the power adjusting circuitry is configured to change the duration of the individual pulses by increasing or decreasing the duration of the individual pulses in a step-wise manner.

17. A system for providing disordered breathing therapy, the system comprising:

at least one electrode configured to stimulate a phrenic nerve of a patient;

at least one sensor configured to generate signals representative of patient respiration comprising signals representative of patient respiration corresponding to unstimulated breathing and signals representative of patient respiration corresponding to stimulated breathing; and

an implantable pulse generator (IPG) configured to:

couple to the at least one electrode and the at least one sensor, and

provide an electrical stimulation signal to the at least one electrode to stimulate the phrenic nerve at a stimulation frequency,

wherein the IPG comprises:

at least one embedded processor configured to:

receive the signals representative of patient respiration over a period of time, and

determine a measure of therapy effectiveness based on a spectrum-based method of comparison of the signals representative of patient respiration corresponding to unstimulated breathing to the signals representative of patient respiration corresponding to stimulated breathing, and

power adjusting circuitry configured to adjust a power of the electrical stimulation signal based on the measure of therapy effectiveness.

18. The system of claim 17 , wherein the at least one sensor comprises a transthoracic impedance sensor.

19. The system of claim 17 , wherein the at least one sensor is configured to sense physiologic activity indicative of contraction of a muscle in response to the electrical stimulation signal.

20. The system of claim 17 , wherein the spectrum-based method of comparison comprises:

a generation of a spectral frequency distribution for the signals representative of patient respiration over the period of time,

an identification of a stimulation frequency band centered on the stimulation frequency corresponding to stimulated breathing,

an identification of a respiration frequency band over a range of natural respiratory frequencies corresponding to unstimulated breathing, and

a calculation of the measure of therapy effectiveness based on a comparison of the stimulation frequency band and the respiration frequency band.

21. The system of claim 20 , wherein the comparison comprises one or more of: a ratio of spectral power in the stimulation frequency band with spectral power in the respiration frequency band,

a ratio of spectral power density in the stimulation frequency band with spectral power density in the respiration frequency band, or

a ratio of spectral magnitude in the stimulation frequency band with spectral magnitude in the respiration frequency band.

22. The system of claim 17 , wherein the IPG is configured to provide the electrical stimulation signal to the at least one electrode to stimulate the phrenic nerve at a variable stimulation frequency based on the measure of therapy effectiveness.

23. The system of claim 17 , wherein the power adjusting circuitry is configured to:

increase the power of the electrical stimulation signal if the measure of therapy effectiveness is below a threshold, and

decrease the power of the electrical stimulation signal if the measure of therapy effectiveness is above the threshold.

24. The system of claim 17 ,

wherein the stimulation frequency is lower than an intrinsic breathing rate of the patient, and

wherein the IPG is configured to control the power adjusting circuitry to adjust the power of the electrical stimulation signal until the power is at an intensity sufficient to entrain respiration while leaving intrinsic drive to breathe intact.

25. The system of claim 17 , wherein the power adjusting circuitry is configured to adjust the power of the electrical stimulation signal by changing one or more of a stimulation current or a stimulation voltage.

26. The system of claim 25 , wherein the power adjusting circuitry is configured to adjust the power of the electrical stimulation signal by increasing or decreasing a current of the electrical stimulation signal by steps within a current range below 10 mA.

27. The system of claim 17 ,

wherein the electrical stimulation signal comprises a series of pulse trains delivered at the stimulation frequency, with each pulse train being composed of a series of individual pulses, and

wherein the power adjusting circuitry is configured to adjust the power of the electrical stimulation signal by changing one or more of: a duration of the individual pulses, an amplitude of the individual pulses, or a frequency of the individual pulses.

28. The system of claim 27 , wherein the power adjusting circuitry is configured to change the duration of the individual pulses by increasing or decreasing the duration of the individual pulses in a step-wise manner.

29. The system of claim 17 , wherein the at least one electrode is one of a cuff electrode or a transvenous lead electrode.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2025
From: PANTELEON, ANTONIOS
To: ZOLL RESPICARDIA, INC.
Reel/Frame 072031/0631 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2024
From: GELFAND, MARK; JAMES, KRISTOFER; WESTLUND, RANDY; PANTELEON, ANTONIOS; GOBLISH, TODD; LYNN, MARK
To: CARDIAC CONCEPTS, INC.
Reel/Frame 066424/0800 →
CHANGE OF NAME Recorded Feb 9, 2024
From: CARDIAC CONCEPTS, INC.
To: RESPICARDIA, INC.
Reel/Frame 066550/0867 →
CHANGE OF NAME Recorded Feb 9, 2024
From: RESPICARDIA, INC.
To: ZOLL RESPICARDIA, INC.
Reel/Frame 066550/0869 →
Continuity (5)
Continuation 17350776 · Jun 17, 2021
Continuation 16002462 · Jun 7, 2018
Continuation 13529770 · Jun 21, 2012
Continuation 12557084 · Sep 10, 2009
Related Publication 20240278010A1 · Aug 22, 2024
References Cited (198)
US 4129125A · Lester et al. · 1978 [cited by applicant]
US 4702253A · Nappholz et al. · 1987 [cited by applicant]
US 4827935A · Geddes et al. · 1989 [cited by applicant]
US 4830008A · Meer · 1989 [cited by applicant]
US 5002067A · Berthelsen et al. · 1991 [cited by applicant]
US 5056519A · Vince · 1991 [cited by applicant]
US 5146918A · Kallok et al. · 1992 [cited by applicant]
US 5170802A · Mehra · 1992 [cited by applicant]
US 5199428A · Obel et al. · 1993 [cited by applicant]
US 5265604A · Vince · 1993 [cited by applicant]
US 5330507A · Schwartz · 1994 [cited by applicant]
US 5423865A · Bowald et al. · 1995 [cited by applicant]
US 5483969A · Testerman et al. · 1996 [cited by applicant]
US 5485851A · Erickson · 1996 [cited by applicant]
US 5524632A · Stein et al. · 1996 [cited by applicant]
US 5578061A · Stroetmann et al. · 1996 [cited by applicant]
US 5922014A · Warman et al. · 1999 [cited by applicant]
US 5938694A · Jaraczewski et al. · 1999 [cited by applicant]
US 6006134A · Hill et al. · 1999 [cited by applicant]
US 6132384A · Christopherson et al. · 2000 [cited by applicant]
US 6212435B1 · Lattner et al. · 2001 [cited by applicant]
US 6266564B1 · Hill et al. · 2001 [cited by applicant]
US 6314324B1 · Lattner et al. · 2001 [cited by applicant]
US 6360740B1 · Ward et al. · 2002 [cited by applicant]
US 6415183B1 · Scheiner et al. · 2002 [cited by applicant]
US 6449507B1 · Hill et al. · 2002 [cited by applicant]
US 6463327B1 · Lurie et al. · 2002 [cited by applicant]
US 6532388B1 · Hill et al. · 2003 [cited by applicant]
US 6537228B1 · Lambert · 2003 [cited by applicant]
US 6542774B2 · Hill et al. · 2003 [cited by applicant]
US 6587726B2 · Lurie et al. · 2003 [cited by applicant]
US 6641542B2 · Cho et al. · 2003 [cited by applicant]
US 6684101B2 · Daum · 2004 [cited by applicant]
US 6718208B2 · Hill et al. · 2004 [cited by applicant]
US RE38705E · Hill et al. · 2005 [cited by applicant]
US 6881192B1 · Park · 2005 [cited by applicant]
US 6890306B2 · Poezevera · 2005 [cited by applicant]
US 6928324B2 · Park et al. · 2005 [cited by applicant]
US 6934583B2 · Weinberg et al. · 2005 [cited by applicant]
US 6937903B2 · Schuler et al. · 2005 [cited by applicant]
US 6964641B2 · Cho et al. · 2005 [cited by applicant]
US 7025730B2 · Cho et al. · 2006 [cited by applicant]
US 7070568B1 · Koh · 2006 [cited by applicant]
US 7077132B2 · Berthon-Jones · 2006 [cited by applicant]
US 7082331B1 · Park et al. · 2006 [cited by applicant]
US 7094207B1 · Koh · 2006 [cited by applicant]
US 7155278B2 · King et al. · 2006 [cited by applicant]
US 7179229B1 · Koh · 2007 [cited by applicant]
US 7184829B2 · Hill et al. · 2007 [cited by applicant]
US 7200442B1 · Koh et al. · 2007 [cited by applicant]
US 7212862B2 · Park et al. · 2007 [cited by applicant]
US 7223244B1 · Koh · 2007 [cited by applicant]
US 7225019B2 · Jahns et al. · 2007 [cited by applicant]
US 7225021B1 · Park et al. · 2007 [cited by applicant]
US 7245971B2 · Park et al. · 2007 [cited by applicant]
US 7269457B2 · Shafer et al. · 2007 [cited by applicant]
US 7269459B1 · Koh · 2007 [cited by applicant]
US 7277757B2 · Casavant et al. · 2007 [cited by applicant]
US 7340302B1 · Falkenberg et al. · 2008 [cited by applicant]
US 7357775B1 · Koh · 2008 [cited by applicant]
US 7361146B1 · Bharmi et al. · 2008 [cited by applicant]
US 7363086B1 · Koh et al. · 2008 [cited by applicant]
US 7371220B1 · Koh et al. · 2008 [cited by applicant]
US 7813805B1 · Farazi · 2010 [cited by applicant]
US 8140164B2 · Tehrani et al. · 2012 [cited by applicant]
US 8233987B2 · Gelfand et al. · 2012 [cited by applicant]
US 8244359B2 · Gelfand et al. · 2012 [cited by applicant]
US 9999768B2 · Gelfand et al. · 2018 [cited by applicant]
US 11065443B2 · Gelfand et al. · 2021 [cited by applicant]
US 11883659B2 · Gelfand · 2024 [cited by examiner]
US 20010003799A1 · Boveja · 2001 [cited by applicant]
US 20020049479A1 · Pitts · 2002 [cited by applicant]
US 20020128563A1 · Carlson et al. · 2002 [cited by applicant]
US 20030078623A1 · Weinberg et al. · 2003 [cited by applicant]
US 20030088244A1 · Swanson et al. · 2003 [cited by applicant]
US 20030195571A1 · Burnes et al. · 2003 [cited by applicant]
US 20050043765A1 · Williams et al. · 2005 [cited by applicant]
US 20050085734A1 · Tehrani · 2005 [cited by applicant]
US 20050085865A1 · Tehrani · 2005 [cited by applicant]
US 20050085866A1 · Tehrani · 2005 [cited by applicant]
US 20050085867A1 · Tehrani et al. · 2005 [cited by applicant]
US 20050085868A1 · Tehrani et al. · 2005 [cited by applicant]
US 20050085869A1 · Tehrani et al. · 2005 [cited by applicant]
US 20050107838A1 · Lovett et al. · 2005 [cited by applicant]
US 20050165457A1 · Benser et al. · 2005 [cited by applicant]
US 20050197588A1 · Freeberg · 2005 [cited by applicant]
US 20050240240A1 · Park et al. · 2005 [cited by applicant]
US 20050288729A1 · Libbus et al. · 2005 [cited by applicant]
US 20060030894A1 · Tehrani · 2006 [cited by applicant]
US 20060036294A1 · Tehrani · 2006 [cited by applicant]
US 20060084060A1 · Nagahama et al. · 2006 [cited by applicant]
US 20060122662A1 · Tehrani et al. · 2006 [cited by applicant]
US 20060142815A1 · Tehrani et al. · 2006 [cited by applicant]
US 20060149334A1 · Tehrani et al. · 2006 [cited by applicant]
US 20060155341A1 · Tehrani et al. · 2006 [cited by applicant]
US 20060167523A1 · Tehrani et al. · 2006 [cited by applicant]
US 20060229677A1 · Moffitt et al. · 2006 [cited by applicant]
US 20060247729A1 · Tehrani et al. · 2006 [cited by applicant]
US 20070021795A1 · Tehrani · 2007 [cited by applicant]
US 20070118183A1 · Gelfand et al. · 2007 [cited by applicant]
US 20070156199A1 · Koh et al. · 2007 [cited by applicant]
US 20070260285A1 · Libbus et al. · 2007 [cited by applicant]
US 20080154330A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080161878A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080167695A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080177347A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080183239A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080183240A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080183254A1 · Bly et al. · 2008 [cited by applicant]
US 20080183259A1 · Bly et al. · 2008 [cited by applicant]
US 20080183264A1 · Bly et al. · 2008 [cited by applicant]
US 20080188903A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080188904A1 · Tehrani et al. · 2008 [cited by applicant]
US 20080234694A1 · Stegfeldt et al. · 2008 [cited by applicant]
US 20090062882A1 · Zhang et al. · 2009 [cited by applicant]
US 20090088827A1 · Tockman et al. · 2009 [cited by applicant]
US 20100249630A1 · Droitcour et al. · 2010 [cited by applicant]
US 20110060380A1 · Gelfand et al. · 2011 [cited by applicant]
US 20120158091A1 · Tehrani et al. · 2012 [cited by applicant]
US 20130296964A1 · Tehrani · 2013 [cited by applicant]
US 20220111202A1 · Gelfand et al. · 2022 [cited by applicant]
DE 10103288A1 · 2002 [cited by applicant]
WO 0141868A1 · 2001 [cited by applicant]
WO 2008046190A1 · 2008 [cited by applicant]
WO 2008092246A1 · 2008 [cited by applicant]
Aiyar, Harish et al., Diaphragm Pacing for Chronic Respiratory Insufficiency, CRC Press, LLC, 2001, Chapter 9. [cited by applicant]
Arzt, Michael et al., Treatment of Sleep Apnea in Heart Failure, Am J Respir Crit Care Med vol. 173, pp. 1300-1308, 2006. [cited by applicant]
Bilgutay, A.M. et al., Augmented Ventilation by Synchronous Phrenic Nerve Stimulation, Trans. Amer. Soc. Artif. Int. Organs, 1970, vol. XVI, pp. 213-217. [cited by applicant]
Brack, Thomas, Cheyne-Stokes Respiration in Patients with Congestive Heart Failure, Seiss Med Wkly 2003; 133:605-610, www.smw.ch. [cited by applicant]
Caples, Sean M. et al., Influence of Cardiac Function and Failure on Sleep-Disordered Breathing, Journal of Applied Physiology 2005, vol. 99, pp. 2433-2439. [cited by applicant]
Chatfield, Paul O. et al., Role of Pulmonary Proprioceptive Reflexes in Suppression of Spontaneous Breathing During Electophrenic Respiration, Dept. of Physiology, Harvard Medical School, and Dept. of Physiology, Harvar… [cited by applicant]
Chinese Application dated Jun. 13, 2016 for corresponding Chinese Application No. 201080040438.2, filed Mar. 12, 2012. [cited by applicant]
Chinese Office Action dated Dec. 19, 2017 for corresponding Chinese Application No. 201610245292.4, filed Apr. 19, 2016. [cited by applicant]
Chinese Office Action dated Dec. 25, 2018 for corresponding Chinese Application No. 201610245292.4, filed Apr. 19, 2016. [cited by applicant]
Chinese Office Action dated May 29, 2018 for corresponding Chinese Application No. 2016102452924, filed Apr. 19, 2016. [cited by applicant]
Chinese Office Action dated Nov. 28, 2016 for corresponding Chinese Application No. 201080040438.2. [cited by applicant]
Chinese Rejection Decision dated Sep. 4, 2018 for corresponding Chinese Application No. 201610245292.4, filed Apr. 19, 2016. [cited by applicant]
Diedrichs, Holger et al., Symptomatic Relief Precedes Improvement of Myocardial Blood Flow in Patients Under Spinal Cord Stimulation, BioMed Central, 2005, pp. 1-7. [cited by applicant]
Dobelle, William H., Use of Breathing Pacemakers to Suppress Intractable Hiccups of up to Thirteen Years Duration, ASAIO Journal 1999, pp. 524-525. [cited by applicant]
Escher, Doris J.W., Clinical control of Respiration by Transvenous Phrenic Pacing, Trans. Amer. Soc. Artif. Int. Organs., vol. XIV, 1968. [cited by applicant]
Esler, Murray et al., Is Obstructive Sleep Apnea the Cause of Sympathetic Nervous Activation in Human Obesity?, Journal of Applied Physiology 2006, vol. 100, pp. 11-12. [cited by applicant]
European Office Action dated Sep. 30, 2010 for European Application No. 06 83 7 985.8-2305. [cited by applicant]
European Search Report dated Aug. 12, 2009 for European Application No. 06837985. [cited by applicant]
European Search Report dated Aug. 19, 2011 for European Application No. 11170415. [cited by applicant]
Extended European Search Report dated Sep. 16, 2016 for corresponding European Patent Application No. 15192744.9, filed Nov. 3, 2015. [cited by applicant]
Extended Search Report dated Apr. 12, 2019 for corresponding European Application No. 17210028.1, filed Dec. 22, 2017. [cited by applicant]
Final Office Action from United States Patent and Trademark Office dated Jun. 8, 2010 for U.S. Appl. No. 11/601,150. [cited by applicant]
Furman, Seymour, MD et al., Transvenous Stimulation of the Phrenic Nerves, Journal of Thoracic and Cardiovascular Surgery, vol. 62, No. 5, 1971, pp. 743-751. [cited by applicant]
Garrido-Garcia, H. et al., Treatment of Chronic Ventilatory Failure Using a Diaphragmatic Pacemaker, Spinal Cord (1998) 36, 310-314. [cited by applicant]
Gottfried, Stewart B. et al., Effects of Phrenic Stimulation on Upper Airway Resistance in Anesthetized Dogs, Am Physiological Society 1983, 0161-7567/83, pp. 419-426. [cited by applicant]
Hall, Michael J. et al., Cycle Length of Periodic Breathing in Patients with and without Heart Failure, Am. J. Respir. Crit. Care Med vol. 154, pp. 376-381, 1996. [cited by applicant]
Handa, Y. et al., Basic Studies on Electrophrenic Respiration Pat 2-Assisted Ventilation by the Synchronous Electrophrenic Respirator, Medical and Biological Engineering, Jul. 1976. [cited by applicant]
Hasdemir, Can MD et al., Jpn Heart J, vol. 44 No. 3, 2003. [cited by applicant]
International Search Report and Written Opinion dated Aug. 15, 2007 for International Application No. PCT/US06/44788. [cited by applicant]
International Search Report dated Aug. 19, 2010 for International Application No. PCT/US2010/045992. [cited by applicant]
International Search Report dated for Oct. 29, 2010 for International Application No. PCT/US2010/045992. [cited by applicant]
Ishii, Kiyoshi, Effects of Bilateral transvenous diaphrahm pacing on hemodynamic function in patients after cardiac operations. 1990. [cited by applicant]
Javaheri, Shahrokh M.D., CPAP Should Not Be Used for Central Sleep Apnea in Congestive Heart Failure Patients, Journal of Clinical Sleep Medicine, vol. 2, No. 4, 2006. [cited by applicant]
Javaheri, Shahrokh, MD, Acetazolamide Improves Central Sleep Apnea in Heart Failure Pulmonary Service, Departrnent of Veterans Affairs Medical Center, and Department of Medicine, University of Cincinnati College of Medi… [cited by applicant]
Javaheri, Shahrokh, MD, Central Sleep Apnea in Congestive Heart Failure: Prevalence, Mechanisms, Impact, and Therapeutic Options, Seminars in Respiratory and Critical Care Medicine, 2005, vol. 26, No. 1. [cited by applicant]
Kaneko, S. et al., A New Approach to Respiratory Assist for Phrenic Nerve Paralysis, Trans Am Soc. Artif Intern Organs, 1985, vol. XXXI, pp. 301-304. [cited by applicant]
Kimura, M. et al., A Heart-Rate-Responsive Diaphragm Pacemaker, Med. & Biol. Eng. & Comput., 1987, 25, 458-462. [cited by applicant]
Kimura, M. et al., Addition to an RF-Coupled Phrenic Nerve Stimulator Implant to Provide Outward Transmission of Body Temperature, Med. & Biol. Eng. & Comput. 1986, 24, 659-661. [cited by applicant]
Kimura, M. et al., Heart Rate and Body Temperature Sensitive Diaphragm Pacing, Med. & Biol. Eng. & Comput. 1992, 30, 155-16. [cited by applicant]
Kingma, John G. Jr. et al., Nueromodulation Therapy Does Not Influence Blood Flow Distribution or Left-Ventricular Dynamics During Acute Myocardial Ischemia, Autonomic Neuroscience; Basic and Clinical 91 (2001) pp. 47-5… [cited by applicant]
Kohnlein, T. et al., Central Sleep Apnea Syndrome in Patients with Chronic Heart Disease: A Critical Review of the Current Literature, Thoarx 2002; 57:547-554. [cited by applicant]
Leuenberger, Urs A. et al., Hypoxia Augments Apnea-Induced Peripheral Vasoconstriction in Humans, Journal of Applied Physiology 2001, vol. 90, pp. 1516-1522. [cited by applicant]
Leung, Richard s. T. et al., Influence of Cheyne-Stokes Respiration on Cardiovascular Oscillations in Heart Failure, Am J Respir Crit Care Med , 2003, vol. 167. pp 1534-1539. [cited by applicant]
Levy, T. et al., A Comparison Between Passive and Active Fixation Leads in the in the Coronary Sinus for Biatrial Pacing, The European Society of Cardiology 2000. [cited by applicant]
Linderoth, Bengt, MD, PHO et al., Mechanisms of Spinal Cord Stimulation in Painful Syndromes: Role of Animals Models, American Academy of Pain Medicine, vol. 7, No. SI4-S26, 2006. [cited by applicant]
Lorenzi-Filho, Geraldo et al., Cheyne-Stokes Respiration in Patients with Congestive Heart Failure: Causes and Consequences, Clinics 2005; 60(4):333-44. [cited by applicant]
MacIntyre, Neil R., MD, Setting the Frequency-Tidal Volume Pattern, www.rcjournal.com/contents/03.02/03.02.0266.asp. [cited by applicant]
Office Action from United States Patent and Trademark Office dated Aug. 20, 2009 for U.S. Appl. No. 11/601,150. [cited by applicant]
Oliven, Arie et al., Upper Airway Response to Electrical Stimulation of the Genioglossus in Obstructive Sleep Apnea, Journal of Applied Physiology, 95:2023-2029, 2003. [cited by applicant]
Parati, Gianfranco et al., Sleep Apnea: Epidemiology, Pathophysiology, and Relation to Cardiovascular Risk, Am Journal Physiological Society 2007, vol. 293, pp. RI671-RI683. [cited by applicant]
Partial European Search Report dated Dec. 19, 2018 for corresponding European Application No. 17210028.1, filed Dec. 22, 2017. [cited by applicant]
Planas, Roque F. et al., Diaphragmatic Pressures: Transvenous vs. Direct Phrenic Nerve Stimulation, Am Physiological Society 1985, 0161-7567/85, pp. 269-273. [cited by applicant]
Plisiene, Jurgita et al., Selective Transvascular Stimulation of Cardiac Autonomic Nerves: A Novel Technique, Biomedicine vol. 2 No. 1, Jul. 2002. [cited by applicant]
Prosecution history for corresponding U.S. Appl. No. 12/557,084, filed Sep. 10, 2009 including: Notice of Allowance and Fee(s) Due mailed Jun. 7, 2012; and Non-Final Rejection mailed Feb. 8, 2012. [cited by applicant]
Prosecution history for corresponding U.S. Appl. No. 13/529,770, filed Jun. 21, 2012 including: Notice of Allowance and Fee(s) Due mailed Mar. 5, 2018, Non-Final Rejection mailed May 8, 2017, Notice of Allowance and Fee… [cited by applicant]
Punjabi, Naresh M. et al., Disorders of Glucose Metabolism in Sleep Apnea, Journal of Applied Physiology 2005, vol. 99, pp. 1998-2007. [cited by applicant]
Redline, Susan et al., Beyond the Fat Boy, Journal of Applied Physiology 2005, vol. 99: pp. 1243-1244. [cited by applicant]
Reexamination Notification dated Feb. 3, 2016, for corresponding Chinese Application No. 201080040438.2, filed Mar. 12, 2012. [cited by applicant]
Restriction Requirement from United States Patent and Trademark Office dated Mar. 23, 2009 for U.S. Appl. No. 11/601,150. [cited by applicant]
Sarnoff, Stanley J. et al., Electrophrenic Respiration IV. The Effectiveness of Contralateral Ventilation During Activity of One Phrenic Nerve, Dept. of Physiology, Harvard School of Public Health, 1949, pp. 929-937. [cited by applicant]
Sarnoff, Stanley J. et al., Electrophrenic Respiration. III. Mechanism of the Inhibition of Spontaneous Respiration, Dept. of Physiology, Harvard School of Public Health, 1948, vol. 155, pp. 203-207. [cited by applicant]
Schauerte, Patrick et al., Catheter Stimulation of Cardiac Parasympathetic Nerves in Humans: A Novel Approach to the Cardiac Autonomic Nervous System, American Heart Association 2006. [cited by applicant]
Series, F. et al., Site of Phrenic Nerve Stimulation-Induced Upper Airway Collapse: Influence of Expiratory Time, Journal of Applied Physiology 2002, vol. 92, pp. 665-671. [cited by applicant]
Series, Frederic, Assessment of Upper Airway Dynamics in Awake Patients with Sleep Apnea Using Phrenic Nerve Stimulation, Am Journal Respir Crit Care Med, 2000, vol. 162., pp. 795-800. [cited by applicant]
Shaul, Donald B., et al., Thoracoscopic Placement of Phrenic Nerve Electrodes for Diaphragmatic Pacing in Children, Journal of Pediatric Surgery, vol. 3 7, No. 7 pp. 974-978, 2002. [cited by applicant]
Stemmer, Edward A. MD et al., Diaphragmatic Pacing in the Treatment of Hypoventilation Syndrome, Journal of Thoracic and Cardiovascular Surgery, vol. 54, No. 5, 1967, pp. 649-657. [cited by applicant]
Taira, Takaomi, MD, Ph. D et al., Phrenic Nerve Stimulation for Diaphragm Pacing with a Spinal cord Stimulator, Elsevier Science, Surg Neurol, 2003; 59:128-32. [cited by applicant]
Tanaka, Satoshi et al., Mechanisms of Sustained Cutaneous Vasodilation Induced by Spinal Cord Stimulation, Autonomic Neuroscience: Basic and Clinical 114 (2004) pp. 55-60. [cited by applicant]
Thoma, H. et al., The Vienna Phrenic Pacemaker, Longterm Data of Failures, 1993. [cited by applicant]
Vaseghi, et al., Beyond Coronary Sinus Angiography: The Value of Coronary Arteriography and Identification of the Pericardiophrenic Vein During Left Ventricular Lead Placement, PACE, 2005, vol. 28. [cited by applicant]
Written Opinion dated for Oct. 29, 2010 for International Application No. PCT/US2010/045992. [cited by applicant]
Yasuma, Fumihiko et al., Eight-Year Follow-Up Study of a Patient with Central Alveolar Hypoventilation Treated with Diaphragm Pacing, Respiration, 1998; 65:313-316. [cited by applicant]
Yumino, Dai et al., Central Sleep Apnea and Cheyne-Stokes Respiration, Proceedings of the American Thoracic Society, 2008, vol. 5, pp. 226-236. [cited by applicant]